Daniel L. Gillen

Picture of Daniel L. Gillen
Chancellor's Professor and Chair, Statistics
Donald Bren School of Information and Computer Sciences
Chancellor's Professor, Epidemiology and Biostatistics
Public Health
Chancellor's Professor, Population Health and Disease Prevention
Public Health
Ph.D., University of Washington, Biostatistics
Phone: (949) 824-9862
Fax: (949) 824-9863
Email: dgillen@uci.edu
University of California, Irvine
2226 Bren Hall (Comp Sci 3)
Mail Code: 1250
Irvine, CA 92697
Research Interests
Survival analysis, longitudinal data analysis, clinical trials, sequential testing, epidemiologic methods
Academic Distinctions
Chancellor's Professor, UC Irvine (2022)
Fellow of the American Statistical Association (Elected 2016)
Dean’s Award for Mid-career Research Excellence, UCI School of Information and Computer Science (2015)
Dean’s Award for Service Excellence, UCI School of Information and Computer Science (2012)
Excellence in Mentoring Award, UCI Institute for Clinical and Translational Sciences (2011)
Donovan J. Thompson Award, Department of Biostatistics, University of Washington (2000)
NIH Cancer-Epidemiology-Biostatistics Training Grant (1999 - 2003)
Research Abstract
My research focuses on the development of statistical methodology for censored survival data, group sequential methods for the design and analysis of clinical trials, and the analysis of longitudinal data. As a general rule, my methodologic research is motivated by applications stemming from a multitude of clinical disciplines. .
Nguyen V.* and Gillen D. “Robust Inference in Semiparametric Discrete Hazard Models for Randomized Clinical Trials”, Lifetime Data Analysis, Vol. 18, No. 4 (2013), pp. 446-69.
Brummel S.* and Gillen D. “Flexibly Monitoring Group Sequential Survival Trials Using Constrained Boundaries”, In Press, Sequential Analysis 2013.
Haneuse S., Schildcrout J., and Gillen D. “A two-stage strategy to accommodate general patterns of confounding in the design of observational studies”, Biostatistics, Vol. 13, No. 2 (2012), pp. 274-88.
Boyd A.*, Kittelson J., and Gillen D. “Estimation of treatment effect under nonproportional hazards and conditionally independent censoring”, Statistics in Medicine, Vol. 31, No. 28 (2012), pp. 3504-15.
Gillen D., “A Random walk approach for quantifying uncertainty in group sequential survival trials”, Computational Statistics & Data Analysis, Vol. 53, No. 3 (2009), pp. 603-620.
Haneuse S., Rudser K., and Gillen D. “Flexible Bayesian survival modeling of the non-stationary effect of a timedependent covariate” (In press, Biostatistics).
Emerson S., Kittelson J., and Gillen D., “Bayesian evaluation of group sequential clinical trial designs”, Statistics In Medicine, Vol. 26, No. 7 (2007), pp. 1431-49.
Gillen D. and Emerson S., “Non-transitivity in a class of weighted logrank statistics under nonproportional hazards”, Statistics and Probability Letters, Vol. 77, No. 2 (2007), pp. 123-130.
Gillen D., Coe F., and Worcester E., “Nephrolithiasis and increased blood pressure among females with increased BMI” American Journal of Kidney Diseases, Vol. 46 (2005), pp. 263-9.
Delfino R., Staimer N., Gillen D., Tjoa T., Sioutas C., Fung K., George S., Kleinman M.. “Personal and ambient air pollution is associated with increased exhaled NO in children with asthma” Environ Health Perspect, Vol. 114, No. 11 (2006), pp. 1736-43.
Vokes T., Gillen D., Pham A., Lovett J., “Risk factors for prevalent vertebral fractures in black and white female densitometry patients.” Journal of Clinical Densitometry, Vol. 10 (2007), pp. 1-9.
Worcester E., Gillen D., Evan A., Parks J., Wright K., Trumbore L., Nakagawa Y., and Coe F., “Evidence that postprandial reduction of renal calcium reabsorption mediates the hypercalcuria of patients with calcium nephrolithiasis”, American Journal of Physiology - Renal Physiology, Vol. 292, No. 1 (2007), pp. 66-75
Professional Societies
American Statistical Association (2003-present)
International Biometric Society (2002-present)
American Society of Nephrology (2004-present)
Other Experience
Assistant Professor
Dept. of Health Studies, University of Chicago 2003—2004
FDA Advisory Committee for Reproductive Health Drugs, Food and Drug Administration
Data Safety Monitoring Committee, Multicenter Trial of Galiximab in Combination with Rituximab, Biogen Idec
Graduate Programs
Research Centers
Genetic Epidemiology Research Institute - Dept. of Epidemiology
Last updated